Abstract:Background: Cardiac troponin is a complex protein consisting of the three subunits I, T and C located in heart muscle cells. When the heart muscle is damaged, it is released into the blood and can be detected. Cardiac troponin I (cTnI) is considered the most reliable and widely accepted test for detecting and confirming acute myocardial infarction. However, there is no current standardization between the commercial assays for cTnI quantification. Our work aims to create a measurement procedure that is traceable to the International System of Units for accurately measuring cardiac cTnI levels in serum samples from patients. Methods: The workflow begins with immobilizing anti-cTnI antibodies onto magnetic nanoparticles to form complexes. These complexes are used to isolate cTnI from serum. Next, trypsin is used to enzymatically digest the isolated cTnI. Finally, the measurement of multiple cTnI peptides is done simultaneously using isotope dilution liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS). Results: The maximum antibody immobilization was achieved by combining 1 mg of nanoparticles with 100 μg of antibody, resulting in an average of 59.2 ± 5.7 μg/mg of immobilized antibody. Subsequently, the anti-cTnI-magnetic nanoparticle complex was utilized to develop and validate a method for quantifying cTnI in human serum using ID-LC-MS/MS and a protein calibration approach. The analytical method was assessed regarding linearity and recovery. The developed method enables the quantification of cTnI from 0.7 to 24 μg/L (R > 0.996). The limit of quantification was 1.8 μg/L and the limit of detection was 0.6 μg/L. Intermediate precision was ≤ 9.6% and repeatability was 2.0-8.7% for all quality control materials. The accuracy of the analyzed quality control materials was between 90 and 110%. Total measurement uncertainties for target value assignment (n = 6) were found to be ≤ 12.5% for all levels. Conclusions: The analytical method demonstrated high analytical performance in accurately quantifying cardiac troponin I levels in human serum. The proposed analytical method has the potential to facilitate the harmonization of cTnI results between clinical laboratories, assign target values to secondary certified reference materials and support reliable measurement of cTnI.

Purification and Identification of human Myocardial Troponin T

Isolation and Purification of Human Cardiac Troponin Ⅰ Using Affinity Chromatography

A Rare Case of Falsely Elevated High-Sensitivity Cardiac Troponin T Due to Antibody Interference and a Literature Review

Cloning and Expression of Human Fetal Cardiac Troponin T Isoform

Construction , Expression of Ctni(28-110Aa)-linker-tnc Fusion Protein and Its Identification

Expression of cTnI Specific Antigen Sites and Antibodies Detection

Development of an ID-LC-MS/MS method using targeted proteomics for quantifying cardiac troponin I in human serum

Antigen Design in Production of Anti-Human Cardiac Troponin Ⅰ Monoclonal Antibody

An Optical Immunosensor Based on Surface Plasmon Resonance for Human cTnI Determination

The Analytical Performance Assessment of High-Sensitivity Cardiac Troponin T Reference Intervals Investigation

Prokaryotic Expression Purification and Identification of Human Amino-Terminal Pro-Brain Natriuretic Peptide and Its Stability

The Expression of Human Ctni and Ctnc in E.coli Andtheir Combination Assay

Preparation of Anti-Human Cardiac Troponin I Immunomagnetic Nanoparticles and Biological Activity Assays

Fouling-Free Electrochemical Strategy based on Vertically-aligned Peptide Layer for Cardiac Troponin I Sensitive Detection in Human Serum

Preparation and Characterization of the Antibodies Against Human Myofibrillogenesis Regulator 1 and Application in Neonatal Rat Cardiomyocytes

Research on Ctni Immunohistochemistry of Human Myocardium in Coronary Heart Disease

Low-noise fluorescent detection of cardiac troponin I in human serum based on surface acoustic wave separation

Washing-free chemiluminescence immunoassay for rapid detection of cardiac troponin I in whole blood samples

Performance evaluation of a novel high-sensitivity cardiac troponin T assay: analytical and clinical perspectives

Composition, structural configuration, and antigenicity of Atlantic cod (Gadus morhua) tropomyosin

High-level expression and purification of human creatine kinase MM isozymes in E.coli